<p>Dr Peter Jones explains genetic diagnostics for FSHD1 and FSHD2. &nbsp;This covers various methods for FSHD deletion testing through the new epigenetic research testing, and the difference between CLIA-approved testing and research testing. &nbsp;The final 20 minutes takes you through your FSHD genetic report if you participated in the epigenetic research testing at the Jones Lab at UNR.</p>

--- 

Send in a voice message: https://podcasters.spotify.com/pod/show/peter-l-jones/message

CRISPR technology for FSHD with Dr. Charis Himeda

MyFSHD is about education and personal empowerment for the worldwide facioscapulohumeral muscular dystrophy (FSHD) community. Here we have discussions and commentary hosted by FSHD researcher Peter Jones, PhD, on many things of interest to the FSHD community. Learn about the science behind the different FSHD therapeutic approaches, FSHD pathology, family genetics and FSHD diagnostics. We will discuss upcoming clinical trials and what to look forward to. You will get to understand how you can be better prepared, become involved, and help contribute to defeating FSHD once and for all.